Counterfeit drugs have developed into a serious global problem in recent years. Even in countries with a safe system for marketing medicinal products, patients must know about the risks. Counterfeit drugs can endanger the health of unsuspecting users or even be life-threatening. Bayer regards it as its duty to stand up for patient safety in the face of the threat posed by counterfeit drugs.
Medicine crime: Inconsistent European legislations
Every country has different laws pertaining medicine crimes. However, the differences can vary so vastly that prosecuting drug counterfeiters across borders can become a very challenging task. This is one of the results of ALPhA, a project funded by the German government (we reported previously on this). The final results were presented in Osnabrück, Germany, at a closing press conference.
“We are in desperate need for a harmonization of medicine laws”, legal scholar Arndt Sinn, from the University of Osnabrück, said to the press. He also criticized authorities for not cooperating closely enough. Former director of Europol, Jürgen Storbeck, urged the German government and authorities to develop a European strategy that takes product piracy and medicine crime more into account.
Furthermore, consumers should be made more aware of counterfeit drugs, experts said. Illegal online pharmacies increasingly are forged to take on the appearance of a legitimate store explained Marina Bloch, in-house counsel at Bayer AG. And counterfeit medicines available at these illegal pharmacies resemble their original counterparts so much that even experts have a hard time distinguishing them from real medication.
August 5, 2016
Sources: University of Osnabrück, DAZ